REQUEST A DEMO
Total
USD $0.00
Search more companies

Scionex Sdn. Bhd. (Malaysia)

Main Activities: Pharmaceutical and Medicine Manufacturing | Miscellaneous Durable Goods Merchant Wholesalers | Pharmacies and Drug Stores
Full name: Scionex Sdn. Bhd. Profile Updated: February 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Scionex Sdn. Bhd. is an enterprise located in Malaysia, with the main office in Petaling Jaya. The company operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on July 12, 2026. The company’s latest financial report indicates a net sales revenue increase of 35.04% in 2024. There was a total growth of 33% in Scionex Sdn. Bhd.’s total assets over the same period. The enterprise’s net profit margin decreased by 1.1% in 2024.

Headquarters
Suite 1.01, Level 1, Block A, Bangunan Panglobal, No.1A, Jalan Tandang
Petaling Jaya; Selangor; Postal Code: 46050

Contact Details: Purchase the Scionex Sdn. Bhd. report to view the information.

Website: http://www.scionex.com.my

Basic Information
Financial Auditors:
Purchase the Scionex Sdn. Bhd. report to view the information.
Incorporation Date:
July 12, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
33.34%
Purchase this report to view the information.
33.34%
Purchase this report to view the information.
33.32%
Company Performance
Financial values in the chart are available after Scionex Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
35.04%
Total Operating Revenue
35.04%
Operating Profit
12.55%
Net Profit/Loss for the Period
19.55%
Total Assets
33%
Total Equity
41.47%
Operating Profit Margin
-2.08%
Net Profit Margin
-1.1%
Return on Equity (ROE)
-6.16%
Quick Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?